Collaborate & Network in Research

Collaboration and partnerships are key to achieving fundamental gains. Increasingly, industry, academia, and health providers are uniting their strengths to be part of a larger, more influential network.

The Kolling Institute of Medical Research is consistently working to strengthen its partnerships, building on networks with the University of Sydney, other leading academic institutions, national and international collaborators, as well as the Northern Sydney Local Health District, government and industry. Community support is also crucial. It is through these relationships that we are able to improve patient outcomes, develop new diagnostics and offer new treatments.

Our location alongside Royal North Shore Hospital gives our researchers unique access to one of Sydney’s largest tertiary hospitals. This allows us to take the lead in the type of research we do and it gives our teams access to clinicians and patients, and state-of-the-art facilities, including imaging and molecular technologies.

Collaboration within the Kolling Institute also plays a crucial role in new discoveries. Our researchers and clinicians specialise in a wide range of clinical care. By bringing these researchers together, we have produced significant advances in medical care often from quite different fields. In one case, a protein known to cause disease during pregnancy may protect the eye from age-induced retinopathy. We are continuing to develop closer ties within our organisation.

Events, News and Seminars

International focus on our ovarian cancer research

International focus on our ovarian cancer research

In an exciting breakthrough, researchers from the Kolling Institute’s Bill Walsh Lab have identified..... Read more

Category: Research Excellence

Home grown ideas place physio in patients' hands

Home grown ideas place physio in patients' hands

New research is testing a new way to meet the rapidly growing demand for physiotherapy in our publi..... Read more

Category: New Treatment

Common medication may lower risk of “heartbreak”

Common medication may lower risk of “heartbreak”

RNSH cardiologist Professor Geoffrey Tofler has led a world-first study which found that common med..... Read more

Category: Research Excellence